Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites.

Cancer research - 15 Nov 2002

Rosin Miriam P, Lam Wan L, Poh Catherine, Le Nhu D, Li Robert Jinze, Zeng Tao, Priddy Robert, Zhang Lewei

Abstract excerpt

Treatment induces reactive changes that often resemble low-grade dysplasia at former oral cancer sites, complicating histopathological assessment. We tested a set of microsatellite markers shown previously to be predictive of progression for oral premalignant lesions for the ability to predict development of second oral malignancy (SOM). Sixty-eight oral leukoplakia at former cancer sites (with known outcome, 36...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma in Situ
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 3

Share to Chromosomes, Human, Pair 9

Share to Leukoplakia, Oral

Share to Loss of Heterozygosity

Share to Mouth Neoplasms

Share to Neoplasms, Second Primary

Source

Identifiers

PMID: 12438233

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites.PMID 12438233Read ↗

Loss of Heterozygosity (LOH) Profiles—Validated Risk Predictors for Progression to Oral CancerSemantic proximity Read ↗

Increased genetic damage in oral leukoplakia from high risk sitesSemantic proximity Read ↗

Molecular screening of oral precancer.Semantic proximity Read ↗

Molecular findings in oral premalignant fields: update on their diagnostic and clinical implications.Semantic proximity Read ↗

3p21, 5q21, 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation.Semantic proximity Read ↗

Multiple Aberrations of Chromosome 3p Detected in Oral Premalignant LesionsSemantic proximity Read ↗

Aneuploidy and loss of heterozygosity as risk markers for malignant transformation in oral mucosaSemantic proximity Read ↗

Molecular markers in oral epithelial dysplasia: reviewSemantic proximity Read ↗

Genetics/epigenetics of oral premalignancy: current status and future research*Semantic proximity Read ↗

Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.Semantic proximity Read ↗

The genetic basis of oral leukoplakia and its key role in understanding oral carcinogenesis.Semantic proximity Read ↗

Recurring DNA copy number gain at chromosome 9p13 plays a role in the activation of multiple candidate oncogenes in progressing oral premalignant lesions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.